# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Feb 6, 2013

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2013-02-06
- Accepted by EDGAR: Feb 6, 2013, 16:57 ET
- Period: not reported
- Accession: 0001144204-13-006496
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114420413006496/v332922_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114420413006496/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114420413006496/v332922_sc13da.htm

Filed Feb 6, 2013.
Source: SEC EDGAR, the filing index for accession 0001144204-13-006496. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.
